Global Rapid Diagnostic Kits Market Size, Share, Opportunities, And Trends By Technology (Lateral Flow Assays, Flow-Through, Agglutination, Solid Phase), By Application (Glucose Monitoring, Cardiometabolic Testing, Infectious Disease Testing, Drugs-of-Abuse Testing, Fertility and Pregnancy Testing, Others), By End Users (Hospitals and Clinics, Diagnostic Centres, Home Care Settings), And By Geography - Forecasts From 2025 To 2030

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL RAPID DIAGNOSTIC KITS MARKET BY TECHNOLOGY

5.1. Introduction

5.2. Lateral Flow Assay

5.3. Agglutination

5.4. Others

6. GLOBAL RAPID DIAGNOSTIC KITS MARKET BY APPLICATION

6.1. Introduction

6.2. Glucose Monitoring

6.3. Cardiometabolic Testing

6.4. Infectious Disease Testing

6.5. Drugs-ON-Abuse Testing

6.6. Fertility & Pregnancy Testing

6.7. Others

7. GLOBAL RAPID DIAGNOSTIC KITS MARKET BY END-USER

7.1. Introduction

7.2. Hospitals & Clinics

7.3. Diagnostics Centers

7.4. Others

8. GLOBAL RAPID DIAGNOSTIC KITS MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. USA

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. Germany

8.4.2. France

8.4.3. United Kingdom

8.4.4. Italy

8.4.5. Spain

8.4.6. Others

8.5. Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Israel

8.5.4. Others

8.6. Asia Pacific

8.6.1. China

8.6.2. India

8.6.3. Japan

8.6.4. South Korea

8.6.5. Indonesia

8.6.6. Thailand

8.6.7. Taiwan

8.6.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Creative Diagnostics

10.2. Abbott Laboratories

10.3. NanoRepro AG

10.4. Atlas Medical UK

10.5. Coris BioConcept

10.6. Roche Diagnostics

10.7. SD Biosensor

10.8. ACON Laboratories Inc.

10.9. Alfa Scientific Designs Inc.

10.10. AdvaCare Pharma 

11. APPENDIX

11.1. Currency 

11.2. Assumptions

11.3. Base and Forecast Years Timeline

11.4. Key benefits for the stakeholders

11.5. Research Methodology 

11.6. Abbreviations 

LIST OF FIGURES

LIST OF TABLES